ADM
22
-2
MCO
68
4
PNW
55
2
MAT
58
9
DIS
73
-2
CLX
68
2
MA
46
2
ADP
66
4
CNP
47
6
EQT
56
2
CHRW
57
-3
MPC
36
3
DUK
60
5
APH
58
5
ALL
43
6
CB
41
2
NFLX
59
-2
CCL
51
3
EXC
67
6
AA
38
-2
ADM
22
-2
MCO
68
4
PNW
55
2
MAT
58
9
DIS
73
-2
CLX
68
2
MA
46
2
ADP
66
4
CNP
47
6
EQT
56
2
CHRW
57
-3
MPC
36
3
DUK
60
5
APH
58
5
ALL
43
6
CB
41
2
NFLX
59
-2
CCL
51
3
EXC
67
6
AA
38
-2
Financhill
Back

Builders FirstSource Vs. Collegium Pharmaceutical Industry Stock Comparison

Sell
22

BLDR
Builders FirstSource

Last Price:
$143.57
Seasonality Move:
15.54%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
22
Builders FirstSource (BLDR) is a Sell

Is Builders FirstSource a Buy, Sell or Hold?

  • The current Builders FirstSource [BLDR] share price is $143.50. The Score for BLDR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • BLDR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLDR Stock Price Chart

What is Builders FirstSource's stock price today?

  • The Builders FirstSource share price today is $143.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing buying pressure, which is a positive indicator for future bullish movement.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

BLDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.3 Sell
Relative Strength Index (14 RSI): 28.92 Sell
Chaikin Money Flow: 949667 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (143.58 - 171.26) Sell
Bollinger Bands (100): (160.17 - 191.11) Sell

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

BLDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 143.73 Sell
20-day SMA: 152.27 Sell
50-day SMA: 168.26 Sell
200-day SMA: 171 Sell
8-day EMA: 145 Sell
20-day EMA: 152.21 Sell
50-day EMA: 163.83 Sell
200-day EMA: 167.43 Sell

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

Builders FirstSource Earnings Growth & BLDR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $2.21 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Builders FirstSource Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):